img

Global Radiopharmaceutical (Oral Route) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiopharmaceutical (Oral Route) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Radiopharmaceutical (Oral Route) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Radiopharmaceutical (Oral Route) market is projected to reach US$ 8804.1 million in 2034, increasing from US$ 6761 million in 2022, with the CAGR of 3.9% during the period of 2024 to 2034. Demand from Oncology and Cardiology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Radiopharmaceutical (Oral Route) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Radiopharmaceutical (Oral Route) key manufacturers include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. Bracco Imaging, Bayer, Mallinckrodt are top 3 players and held % sales share in total in 2022.
Radiopharmaceutical (Oral Route) can be divided into Actinium-225, Lutetium-177, Radium-223 and Holmium-166, etc. Actinium-225 is the mainstream product in the market, accounting for % sales share globally in 2022.
Radiopharmaceutical (Oral Route) is widely used in various fields, such as Oncology, Cardiology and Other,, etc. Oncology provides greatest supports to the Radiopharmaceutical (Oral Route) industry development. In 2022, global % sales of Radiopharmaceutical (Oral Route) went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Radiopharmaceutical (Oral Route) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Segment by Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other

Segment by Application


Oncology
Cardiology
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Radiopharmaceutical (Oral Route) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Radiopharmaceutical (Oral Route), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Radiopharmaceutical (Oral Route) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Radiopharmaceutical (Oral Route) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Radiopharmaceutical (Oral Route) introduction, etc. Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Radiopharmaceutical (Oral Route) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Radiopharmaceutical (Oral Route) Market Overview
1.1 Radiopharmaceutical (Oral Route) Product Overview
1.2 Radiopharmaceutical (Oral Route) Market Segment by Type
1.2.1 Actinium-225
1.2.2 Lutetium-177
1.2.3 Radium-223
1.2.4 Holmium-166
1.2.5 Other
1.3 Global Radiopharmaceutical (Oral Route) Market Size by Type
1.3.1 Global Radiopharmaceutical (Oral Route) Market Size Overview by Type (2024-2034)
1.3.2 Global Radiopharmaceutical (Oral Route) Historic Market Size Review by Type (2024-2024)
1.3.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2024-2024)
1.4.2 Europe Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Breakdown by Type (2024-2024)
2 Global Radiopharmaceutical (Oral Route) Market Competition by Company
2.1 Global Top Players by Radiopharmaceutical (Oral Route) Sales (2024-2024)
2.2 Global Top Players by Radiopharmaceutical (Oral Route) Revenue (2024-2024)
2.3 Global Top Players by Radiopharmaceutical (Oral Route) Price (2024-2024)
2.4 Global Top Manufacturers Radiopharmaceutical (Oral Route) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Radiopharmaceutical (Oral Route) Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical (Oral Route) Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical (Oral Route) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical (Oral Route) as of 2022)
2.7 Date of Key Manufacturers Enter into Radiopharmaceutical (Oral Route) Market
2.8 Key Manufacturers Radiopharmaceutical (Oral Route) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Radiopharmaceutical (Oral Route) Status and Outlook by Region
3.1 Global Radiopharmaceutical (Oral Route) Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Radiopharmaceutical (Oral Route) Historic Market Size by Region
3.2.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Region (2024-2024)
3.2.2 Global Radiopharmaceutical (Oral Route) Sales in Value by Region (2024-2024)
3.2.3 Global Radiopharmaceutical (Oral Route) Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Region
3.3.1 Global Radiopharmaceutical (Oral Route) Sales in Volume by Region (2024-2034)
3.3.2 Global Radiopharmaceutical (Oral Route) Sales in Value by Region (2024-2034)
3.3.3 Global Radiopharmaceutical (Oral Route) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Radiopharmaceutical (Oral Route) by Application
4.1 Radiopharmaceutical (Oral Route) Market Segment by Application
4.1.1 Oncology
4.1.2 Cardiology
4.1.3 Other
4.2 Global Radiopharmaceutical (Oral Route) Market Size by Application
4.2.1 Global Radiopharmaceutical (Oral Route) Market Size Overview by Application (2024-2034)
4.2.2 Global Radiopharmaceutical (Oral Route) Historic Market Size Review by Application (2024-2024)
4.2.3 Global Radiopharmaceutical (Oral Route) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2024-2024)
4.3.2 Europe Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Radiopharmaceutical (Oral Route) Sales Breakdown by Application (2024-2024)
5 North America Radiopharmaceutical (Oral Route) by Country
5.1 North America Radiopharmaceutical (Oral Route) Historic Market Size by Country
5.1.1 North America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2024)
5.1.3 North America Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2024)
5.2 North America Radiopharmaceutical (Oral Route) Forecasted Market Size by Country
5.2.1 North America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2034)
5.2.2 North America Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2034)
6 Europe Radiopharmaceutical (Oral Route) by Country
6.1 Europe Radiopharmaceutical (Oral Route) Historic Market Size by Country
6.1.1 Europe Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2024)
6.1.3 Europe Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2024)
6.2 Europe Radiopharmaceutical (Oral Route) Forecasted Market Size by Country
6.2.1 Europe Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2034)
6.2.2 Europe Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2034)
7 Asia-Pacific Radiopharmaceutical (Oral Route) by Region
7.1 Asia-Pacific Radiopharmaceutical (Oral Route) Historic Market Size by Region
7.1.1 Asia-Pacific Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Radiopharmaceutical (Oral Route) Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Radiopharmaceutical (Oral Route) Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Radiopharmaceutical (Oral Route) Forecasted Market Size by Region
7.2.1 Asia-Pacific Radiopharmaceutical (Oral Route) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Radiopharmaceutical (Oral Route) Sales in Value by Region (2024-2034)
8 Latin America Radiopharmaceutical (Oral Route) by Country
8.1 Latin America Radiopharmaceutical (Oral Route) Historic Market Size by Country
8.1.1 Latin America Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2024)
8.1.3 Latin America Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2024)
8.2 Latin America Radiopharmaceutical (Oral Route) Forecasted Market Size by Country
8.2.1 Latin America Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2034)
9 Middle East and Africa Radiopharmaceutical (Oral Route) by Country
9.1 Middle East and Africa Radiopharmaceutical (Oral Route) Historic Market Size by Country
9.1.1 Middle East and Africa Radiopharmaceutical (Oral Route) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Radiopharmaceutical (Oral Route) Forecasted Market Size by Country
9.2.1 Middle East and Africa Radiopharmaceutical (Oral Route) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Radiopharmaceutical (Oral Route) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bracco Imaging
10.1.1 Bracco Imaging Company Information
10.1.2 Bracco Imaging Introduction and Business Overview
10.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bracco Imaging Radiopharmaceutical (Oral Route) Products Offered
10.1.5 Bracco Imaging Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Bayer Radiopharmaceutical (Oral Route) Products Offered
10.2.5 Bayer Recent Development
10.3 Mallinckrodt
10.3.1 Mallinckrodt Company Information
10.3.2 Mallinckrodt Introduction and Business Overview
10.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Mallinckrodt Radiopharmaceutical (Oral Route) Products Offered
10.3.5 Mallinckrodt Recent Development
10.4 Nordion
10.4.1 Nordion Company Information
10.4.2 Nordion Introduction and Business Overview
10.4.3 Nordion Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Nordion Radiopharmaceutical (Oral Route) Products Offered
10.4.5 Nordion Recent Development
10.5 Triad Isotopes
10.5.1 Triad Isotopes Company Information
10.5.2 Triad Isotopes Introduction and Business Overview
10.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Triad Isotopes Radiopharmaceutical (Oral Route) Products Offered
10.5.5 Triad Isotopes Recent Development
10.6 Lantheus
10.6.1 Lantheus Company Information
10.6.2 Lantheus Introduction and Business Overview
10.6.3 Lantheus Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Lantheus Radiopharmaceutical (Oral Route) Products Offered
10.6.5 Lantheus Recent Development
10.7 IBA Group
10.7.1 IBA Group Company Information
10.7.2 IBA Group Introduction and Business Overview
10.7.3 IBA Group Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.7.4 IBA Group Radiopharmaceutical (Oral Route) Products Offered
10.7.5 IBA Group Recent Development
10.8 GE Healthcare
10.8.1 GE Healthcare Company Information
10.8.2 GE Healthcare Introduction and Business Overview
10.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.8.4 GE Healthcare Radiopharmaceutical (Oral Route) Products Offered
10.8.5 GE Healthcare Recent Development
10.9 China Isotope & Radiation
10.9.1 China Isotope & Radiation Company Information
10.9.2 China Isotope & Radiation Introduction and Business Overview
10.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.9.4 China Isotope & Radiation Radiopharmaceutical (Oral Route) Products Offered
10.9.5 China Isotope & Radiation Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Jubilant Pharma Radiopharmaceutical (Oral Route) Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Eli Lilly
10.11.1 Eli Lilly Company Information
10.11.2 Eli Lilly Introduction and Business Overview
10.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Eli Lilly Radiopharmaceutical (Oral Route) Products Offered
10.11.5 Eli Lilly Recent Development
10.12 Advanced Accelerator Applications
10.12.1 Advanced Accelerator Applications Company Information
10.12.2 Advanced Accelerator Applications Introduction and Business Overview
10.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Products Offered
10.12.5 Advanced Accelerator Applications Recent Development
10.13 SIEMENS
10.13.1 SIEMENS Company Information
10.13.2 SIEMENS Introduction and Business Overview
10.13.3 SIEMENS Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.13.4 SIEMENS Radiopharmaceutical (Oral Route) Products Offered
10.13.5 SIEMENS Recent Development
10.14 Dongcheng
10.14.1 Dongcheng Company Information
10.14.2 Dongcheng Introduction and Business Overview
10.14.3 Dongcheng Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Dongcheng Radiopharmaceutical (Oral Route) Products Offered
10.14.5 Dongcheng Recent Development
10.15 Navidea
10.15.1 Navidea Company Information
10.15.2 Navidea Introduction and Business Overview
10.15.3 Navidea Radiopharmaceutical (Oral Route) Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Navidea Radiopharmaceutical (Oral Route) Products Offered
10.15.5 Navidea Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Radiopharmaceutical (Oral Route) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Radiopharmaceutical (Oral Route) Industrial Chain Analysis
11.4 Radiopharmaceutical (Oral Route) Market Dynamics
11.4.1 Radiopharmaceutical (Oral Route) Industry Trends
11.4.2 Radiopharmaceutical (Oral Route) Market Drivers
11.4.3 Radiopharmaceutical (Oral Route) Market Challenges
11.4.4 Radiopharmaceutical (Oral Route) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Radiopharmaceutical (Oral Route) Distributors
12.3 Radiopharmaceutical (Oral Route) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Actinium-225
Table 2. Major Company of Lutetium-177
Table 3. Major Company of Radium-223
Table 4. Major Company of Holmium-166
Table 5. Major Company of Other
Table 6. Global Radiopharmaceutical (Oral Route) Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 7. Global Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (K Units)
Table 8. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type (2024-2024)
Table 9. Global Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US& Million)
Table 10. Global Radiopharmaceutical (Oral Route) Market Share in Value by Type (2024-2024)
Table 11. Global Radiopharmaceutical (Oral Route) Price by Type (2024-2024) & (US$/Unit)
Table 12. Global Radiopharmaceutical (Oral Route) Sales by Type (2024-2034) & (K Units)
Table 13. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Radiopharmaceutical (Oral Route) Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type (2024-2034)
Table 16. Global Radiopharmaceutical (Oral Route) Price by Type (2024-2034) & (US$/Unit)
Table 17. North America Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (K Units)
Table 18. North America Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US$ Million)
Table 19. Europe Radiopharmaceutical (Oral Route) Sales (K Units) by Type (2024-2024)
Table 20. Europe Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US$ Million)
Table 21. Asia-Pacific Radiopharmaceutical (Oral Route) Sales (K Units) by Type (2024-2024)
Table 22. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US$ Million)
Table 23. Latin America Radiopharmaceutical (Oral Route) Sales (K Units) by Type (2024-2024)
Table 24. Latin America Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US$ Million)
Table 25. Middle East and Africa Radiopharmaceutical (Oral Route) Sales (K Units) by Type (2024-2024)
Table 26. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Type (2024-2024) & (US$ Million)
Table 27. Global Radiopharmaceutical (Oral Route) Sales by Company (2024-2024) & (K Units)
Table 28. Global Radiopharmaceutical (Oral Route) Sales Share by Company (2024-2024)
Table 29. Global Radiopharmaceutical (Oral Route) Revenue by Company (2024-2024) & (US$ Million)
Table 30. Global Radiopharmaceutical (Oral Route) Revenue Share by Company (2024-2024)
Table 31. Global Market Radiopharmaceutical (Oral Route) Price by Company (2024-2024) & (US$/Unit)
Table 32. Global Radiopharmaceutical (Oral Route) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Radiopharmaceutical (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceutical (Oral Route) as of 2022)
Table 35. Date of Key Manufacturers Enter into Radiopharmaceutical (Oral Route) Market
Table 36. Key Manufacturers Radiopharmaceutical (Oral Route) Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Radiopharmaceutical (Oral Route) Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Global Radiopharmaceutical (Oral Route) Sales by Region (2024-2024) & (K Units)
Table 40. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2024-2024)
Table 41. Global Radiopharmaceutical (Oral Route) Sales by Region (2024-2024) & (US$ Million)
Table 42. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2024-2024)
Table 43. Global Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 44. Global Radiopharmaceutical (Oral Route) Sales by Region (2024-2034) & (K Units)
Table 45. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Radiopharmaceutical (Oral Route) Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2024-2034)
Table 48. Global Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 49. Global Radiopharmaceutical (Oral Route) Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 50. Global Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (K Units)
Table 51. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application (2024-2024)
Table 52. Global Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 53. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application (2024-2024)
Table 54. Global Radiopharmaceutical (Oral Route) Price by Application (2024-2024) & (US$/Unit)
Table 55. Global Radiopharmaceutical (Oral Route) Sales by Application (2024-2034) & (K Units)
Table 56. Global Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Radiopharmaceutical (Oral Route) Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application (2024-2034)
Table 59. Global Radiopharmaceutical (Oral Route) Price by Application (2024-2034) & (US$/Unit)
Table 60. North America Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) (K Units)
Table 61. North America Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 62. Europe Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) (K Units)
Table 63. Europe Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 64. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) (K Units)
Table 65. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 66. Latin America Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) (K Units)
Table 67. Latin America Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 68. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) (K Units)
Table 69. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Application (2024-2024) & (US$ Million)
Table 70. North America Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (K Units)
Table 71. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2024)
Table 72. North America Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (US$ Million)
Table 73. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2024)
Table 74. North America Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 75. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (K Units)
Table 79. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2024)
Table 80. Europe Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (US$ Million)
Table 81. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2024)
Table 82. Europe Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 83. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2024-2024) & (K Units)
Table 87. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2024-2024)
Table 88. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2024-2024) & (US$ Million)
Table 89. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2024-2024)
Table 90. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Radiopharmaceutical (Oral Route) Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (K Units)
Table 95. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2024)
Table 96. Latin America Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (US$ Million)
Table 97. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2024)
Table 98. Latin America Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (K Units)
Table 103. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2024)
Table 104. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2024-2024) & (US$ Million)
Table 105. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2024)
Table 106. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Radiopharmaceutical (Oral Route) Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Country (2024-2034)
Table 110. Bracco Imaging Company Information
Table 111. Bracco Imaging Introduction and Business Overview
Table 112. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Bracco Imaging Radiopharmaceutical (Oral Route) Product
Table 114. Bracco Imaging Recent Development
Table 115. Bayer Company Information
Table 116. Bayer Introduction and Business Overview
Table 117. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Bayer Radiopharmaceutical (Oral Route) Product
Table 119. Bayer Recent Development
Table 120. Mallinckrodt Company Information
Table 121. Mallinckrodt Introduction and Business Overview
Table 122. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Mallinckrodt Radiopharmaceutical (Oral Route) Product
Table 124. Mallinckrodt Recent Development
Table 125. Nordion Company Information
Table 126. Nordion Introduction and Business Overview
Table 127. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Nordion Radiopharmaceutical (Oral Route) Product
Table 129. Nordion Recent Development
Table 130. Triad Isotopes Company Information
Table 131. Triad Isotopes Introduction and Business Overview
Table 132. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. Triad Isotopes Radiopharmaceutical (Oral Route) Product
Table 134. Triad Isotopes Recent Development
Table 135. Lantheus Company Information
Table 136. Lantheus Introduction and Business Overview
Table 137. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Lantheus Radiopharmaceutical (Oral Route) Product
Table 139. Lantheus Recent Development
Table 140. IBA Group Company Information
Table 141. IBA Group Introduction and Business Overview
Table 142. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. IBA Group Radiopharmaceutical (Oral Route) Product
Table 144. IBA Group Recent Development
Table 145. GE Healthcare Company Information
Table 146. GE Healthcare Introduction and Business Overview
Table 147. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. GE Healthcare Radiopharmaceutical (Oral Route) Product
Table 149. GE Healthcare Recent Development
Table 150. China Isotope & Radiation Company Information
Table 151. China Isotope & Radiation Introduction and Business Overview
Table 152. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product
Table 154. China Isotope & Radiation Recent Development
Table 155. Jubilant Pharma Company Information
Table 156. Jubilant Pharma Introduction and Business Overview
Table 157. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Jubilant Pharma Radiopharmaceutical (Oral Route) Product
Table 159. Jubilant Pharma Recent Development
Table 160. Eli Lilly Company Information
Table 161. Eli Lilly Introduction and Business Overview
Table 162. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Eli Lilly Radiopharmaceutical (Oral Route) Product
Table 164. Eli Lilly Recent Development
Table 165. Advanced Accelerator Applications Company Information
Table 166. Advanced Accelerator Applications Introduction and Business Overview
Table 167. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product
Table 169. Advanced Accelerator Applications Recent Development
Table 170. SIEMENS Company Information
Table 171. SIEMENS Introduction and Business Overview
Table 172. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 173. SIEMENS Radiopharmaceutical (Oral Route) Product
Table 174. SIEMENS Recent Development
Table 175. Dongcheng Company Information
Table 176. Dongcheng Introduction and Business Overview
Table 177. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 178. Dongcheng Radiopharmaceutical (Oral Route) Product
Table 179. Dongcheng Recent Development
Table 180. Navidea Company Information
Table 181. Navidea Introduction and Business Overview
Table 182. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 183. Navidea Radiopharmaceutical (Oral Route) Product
Table 184. Navidea Recent Development
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Radiopharmaceutical (Oral Route) Market Trends
Table 188. Radiopharmaceutical (Oral Route) Market Drivers
Table 189. Radiopharmaceutical (Oral Route) Market Challenges
Table 190. Radiopharmaceutical (Oral Route) Market Restraints
Table 191. Radiopharmaceutical (Oral Route) Distributors List
Table 192. Radiopharmaceutical (Oral Route) Downstream Customers
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical (Oral Route) Product Picture
Figure 2. Global Radiopharmaceutical (Oral Route) Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Radiopharmaceutical (Oral Route) Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Radiopharmaceutical (Oral Route) Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Actinium-225
Figure 6. Global Actinium-225 Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Lutetium-177
Figure 8. Global Lutetium-177 Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Radium-223
Figure 10. Global Radium-223 Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Holmium-166
Figure 12. Global Holmium-166 Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Global Radiopharmaceutical (Oral Route) Sales by Type (2024-2034) & (US$ Million)
Figure 16. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type in 2022 & 2034
Figure 17. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 18. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2022
Figure 19. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 20. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2022
Figure 23. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical (Oral Route) Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical (Oral Route) Revenue in 2022
Figure 29. Radiopharmaceutical (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Product Picture of Oncology
Figure 31. Global Oncology Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Cardiology
Figure 33. Global Cardiology Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Radiopharmaceutical (Oral Route) Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application in 2022 & 2034
Figure 38. North America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 39. North America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2022
Figure 40. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 41. Europe Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2022
Figure 44. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Radiopharmaceutical (Oral Route) Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Radiopharmaceutical (Oral Route) Manufacturing Cost Structure
Figure 49. Radiopharmaceutical (Oral Route) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries